Brief Report: Androgen Receptor Expression Is Associated With Male Predominance in Thymic Neuroendocrine Neoplasms

IF 3.6 Q2 ONCOLOGY
JTO Clinical and Research Reports Pub Date : 2026-04-01 Epub Date: 2026-02-13 DOI:10.1016/j.jtocrr.2026.100973
Christopher S. Nabel MD, PhD , Chad B. Sussman MD , Charles A. Whittaker PhD , Vincent L. Butty MD, PhD , Jennifer L. Peterson BA , Haley K. Martin BA , Abner Louissaint Jr. MD, PhD , Eva Bru-Tari PhD , Simona Chera PhD , Azra H. Ligon PhD , Beow Y. Yeap ScD , Pedro L. Herrera PhD , Yin P. Hung MD, PhD
{"title":"Brief Report: Androgen Receptor Expression Is Associated With Male Predominance in Thymic Neuroendocrine Neoplasms","authors":"Christopher S. Nabel MD, PhD ,&nbsp;Chad B. Sussman MD ,&nbsp;Charles A. Whittaker PhD ,&nbsp;Vincent L. Butty MD, PhD ,&nbsp;Jennifer L. Peterson BA ,&nbsp;Haley K. Martin BA ,&nbsp;Abner Louissaint Jr. MD, PhD ,&nbsp;Eva Bru-Tari PhD ,&nbsp;Simona Chera PhD ,&nbsp;Azra H. Ligon PhD ,&nbsp;Beow Y. Yeap ScD ,&nbsp;Pedro L. Herrera PhD ,&nbsp;Yin P. Hung MD, PhD","doi":"10.1016/j.jtocrr.2026.100973","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Neuroendocrine neoplasms represent a rare and poorly understood collection of malignancies. A better understanding of their biology is needed to improve treatment options. Male predominance to the incidence of neuroendocrine neoplasms of the thymus suggests a biological basis for this observation.</div></div><div><h3>Methods</h3><div>This single-institution, retrospective cohort study evaluated androgen receptor (AR) expression and other clinicopathologic features in thymic neuroendocrine neoplasms compared with thymic epithelial tumors and neuroendocrine neoplasms of other sites. Expression of neuroendocrine and prostate markers was also assessed. For further molecular characterization, copy number analysis of AR and other relevant genes was assessed by single nucleotide polymorphism array. Last, analysis of single genes and thymic epithelial gene sets was performed using published thymic tumor transcriptomes.</div></div><div><h3>Results</h3><div>A cohort was assembled from 17 patients with neuroendocrine malignancies of primary thymic origin with assessable tissue for immunohistochemical analysis. The cohort was predominantly male (12 males, five females). Immunohistochemical analysis of the AR demonstrated positive staining in nine cases, all of which were male. Compared with thymic neuroendocrine neoplasms, AR expression is considerably less frequent in thymomas, thymic carcinoma, and neuroendocrine neoplasms of other sites of origin. No relevant copy number changes in the AR were identified. Further molecular characterization revealed expression of ASCL1 and limited expression of common prostate lineage and differentiation markers within our cohort, including thymic neuroendocrine epithelial gene set enrichment in published transcriptomes of thymic neuroendocrine neoplasms.</div></div><div><h3>Conclusion</h3><div>The AR is expressed in a considerable fraction of thymic neuroendocrine neoplasms and is associated with male predominance. This observation has implications for investigation of androgen deprivation and receptor blockade.</div></div>","PeriodicalId":17675,"journal":{"name":"JTO Clinical and Research Reports","volume":"7 4","pages":"Article 100973"},"PeriodicalIF":3.6000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JTO Clinical and Research Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S266636432600024X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/13 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Neuroendocrine neoplasms represent a rare and poorly understood collection of malignancies. A better understanding of their biology is needed to improve treatment options. Male predominance to the incidence of neuroendocrine neoplasms of the thymus suggests a biological basis for this observation.

Methods

This single-institution, retrospective cohort study evaluated androgen receptor (AR) expression and other clinicopathologic features in thymic neuroendocrine neoplasms compared with thymic epithelial tumors and neuroendocrine neoplasms of other sites. Expression of neuroendocrine and prostate markers was also assessed. For further molecular characterization, copy number analysis of AR and other relevant genes was assessed by single nucleotide polymorphism array. Last, analysis of single genes and thymic epithelial gene sets was performed using published thymic tumor transcriptomes.

Results

A cohort was assembled from 17 patients with neuroendocrine malignancies of primary thymic origin with assessable tissue for immunohistochemical analysis. The cohort was predominantly male (12 males, five females). Immunohistochemical analysis of the AR demonstrated positive staining in nine cases, all of which were male. Compared with thymic neuroendocrine neoplasms, AR expression is considerably less frequent in thymomas, thymic carcinoma, and neuroendocrine neoplasms of other sites of origin. No relevant copy number changes in the AR were identified. Further molecular characterization revealed expression of ASCL1 and limited expression of common prostate lineage and differentiation markers within our cohort, including thymic neuroendocrine epithelial gene set enrichment in published transcriptomes of thymic neuroendocrine neoplasms.

Conclusion

The AR is expressed in a considerable fraction of thymic neuroendocrine neoplasms and is associated with male predominance. This observation has implications for investigation of androgen deprivation and receptor blockade.
简要报告:雄激素受体表达与胸腺神经内分泌肿瘤中男性优势相关
神经内分泌肿瘤是一种罕见且鲜为人知的恶性肿瘤。为了改善治疗方案,需要更好地了解它们的生物学特性。男性在胸腺神经内分泌肿瘤发病率上的优势提示了这一观察的生物学基础。方法本研究采用单机构、回顾性队列研究,比较胸腺神经内分泌肿瘤与胸腺上皮肿瘤及其他部位神经内分泌肿瘤的雄激素受体(AR)表达及其他临床病理特征。同时评估神经内分泌和前列腺标志物的表达。为了进一步进行分子表征,利用单核苷酸多态性阵列对AR和其他相关基因进行拷贝数分析。最后,使用已发表的胸腺肿瘤转录组进行单基因和胸腺上皮基因组的分析。结果对17例原发性胸腺源性神经内分泌恶性肿瘤患者进行了免疫组化分析。该队列以男性为主(12名男性,5名女性)。免疫组化分析显示9例AR阳性,均为男性。与胸腺神经内分泌肿瘤相比,AR在胸腺瘤、胸腺癌和其他起源部位的神经内分泌肿瘤中的表达频率要低得多。未发现AR中相关的拷贝数变化。进一步的分子表征揭示了ASCL1的表达和共同前列腺谱系和分化标记的有限表达,包括胸腺神经内分泌肿瘤转录组中胸腺神经内分泌上皮基因集的富集。结论AR在胸腺神经内分泌肿瘤中有相当比例的表达,且与男性优势相关。这一观察结果对雄激素剥夺和受体阻断的研究具有启示意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.20
自引率
0.00%
发文量
145
审稿时长
19 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书